335: Garnering Investor Recognition | Josh Blacher, CFO of Therapix Biosciences
CFO THOUGHT LEADER - Podcast tekijän mukaan The Future of Finance is Listening
Kategoriat:
A brief summary of this episode
CFO THOUGHT LEADER - Podcast tekijän mukaan The Future of Finance is Listening
A brief summary of this episode